BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30208959)

  • 1. Demographic, clinical, and pathological features of early onset pancreatic cancer patients.
    Ntala C; Debernardi S; Feakins RM; Crnogorac-Jurcevic T
    BMC Gastroenterol; 2018 Sep; 18(1):139. PubMed ID: 30208959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset pancreatic cancer: a population-based study using the SEER registry.
    Ansari D; Althini C; Ohlsson H; Andersson R
    Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset pancreatic cancer: risk factors, presentation and outcome.
    Piciucchi M; Capurso G; Valente R; Larghi A; Archibugi L; Signoretti M; Stigliano S; Zerboni G; Barucca V; La Torre M; Cavallini M; Costamagna G; Marchetti P; Ziparo V; Delle Fave G
    Pancreatology; 2015; 15(2):151-5. PubMed ID: 25708929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursor lesions of early onset pancreatic cancer.
    Liszka L; Pająk J; Mrowiec S; Zielińska-Pająk E; Gołka D; Lampe P
    Virchows Arch; 2011 Apr; 458(4):439-51. PubMed ID: 21369801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.
    Whitley A; Kocián P; Nikov A; Krejčí D; Pehalová L; Blaha M; Dušek L; Gürlich R
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1324-1333. PubMed ID: 37750364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics, treatment patterns and survival outcomes of early-onset pancreatic adenocarcinoma: a population-based study.
    Ren S; Sadula A; Ye C; Chen Q; Yuan M; Meng M; Lei J; Li G; Yuan C
    Am J Transl Res; 2023; 15(1):407-421. PubMed ID: 36777821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection.
    Zironda A; Zhang C; Day C; McWilliams RR; Starlinger P; Warner SG; Smoot RL; Cleary SP; Kendrick ML; Truty MJ; Thiels CA
    HPB (Oxford); 2024 Jan; 26(1):145-153. PubMed ID: 37752029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
    Tsang ES; Topham JT; Karasinska JM; Lee MKC; Williamson LM; Mendis S; Denroche RE; Jang GH; Kalloger SE; Moore RA; Mungall AJ; Bathe OF; Tang PA; Notta F; Wilson JM; Laskin J; O'Kane GM; Knox JJ; Goodwin RA; Loree JM; Jones SJM; Marra MA; Gallinger S; Schaeffer DF; Renouf DJ
    Clin Cancer Res; 2021 Jan; 27(1):246-254. PubMed ID: 32958704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.
    Takeda T; Sasaki T; Inoue Y; Okamoto T; Mori C; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Takahashi Y; Saiura A; Sasahira N
    Pancreatology; 2022 May; 22(4):507-515. PubMed ID: 35422382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset pancreatic cancer: a controlled trial.
    Tingstedt B; Weitkämper C; Andersson R
    Ann Gastroenterol; 2011; 24(3):206-212. PubMed ID: 24713777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
    Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
    J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of second primary pancreatic cancer.
    Jo JH; Cho IR; Jung JH; Lee HS; Chung MJ; Bang S; Park SW; Chung JB; Song SY; Park JY
    PLoS One; 2017; 12(6):e0179784. PubMed ID: 28650984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.
    Yamamoto T; Satoi S; Kawai M; Motoi F; Sho M; Uemura KI; Matsumoto I; Honda G; Okada KI; Akahori T; Toyama H; Kurata M; Yanagimoto H; Yamaue H; Unno M; Kon M; Murakami Y
    Pancreatology; 2018 Jan; 18(1):106-113. PubMed ID: 29153701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and non-genetic risk factors for early-onset pancreatic cancer.
    Nodari Y; Gentiluomo M; Mohelnikova-Duchonova B; Kreivenaite E; Milanetto AC; Skieceviciene J; Landi S; Lawlor RT; Petrone MC; Arcidiacono PG; Lovecek M; Gazouli M; Bijlsma MF; Morelli L; Kiudelis V; Tacelli M; Zanette DL; Soucek P; Uzunoglu F; Kaaks R; Izbicki J; Boggi U; Pezzilli R; Mambrini A; Pasquali C; van Laarhoven HW; Katzke V; Cavestro GM; Sperti C; Loos M; Latiano A; Erőss B; Oliverius M; Johnson T; Basso D; Neoptolemos JP; Aoki MN; Greenhalf W; Vodicka P; Archibugi L; Vanella G; Lucchesi M; Talar-Wojnarowska R; Jamroziak K; Saeedi MA; van Eijck CHJ; Kupcinskas J; Hussein T; Puzzono M; Bunduc S; Götz M; Carrara S; Szentesi A; Tavano F; Moz S; Hegyi P; Luchini C; Capurso G; Perri F; Ermini S; Theodoropoulos G; Capretti G; Palmieri O; Ginocchi L; Furbetta N; Canzian F; Campa D
    Dig Liver Dis; 2023 Oct; 55(10):1417-1425. PubMed ID: 36973108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.
    He J; Edil BH; Cameron JL; Schulick RD; Hruban RH; Herman JM; Zheng L; Iacobuzio-Donahue C; Ahuja N; Pawlik TM; Wolfgang CL
    J Gastrointest Surg; 2013 Feb; 17(2):339-44. PubMed ID: 23184271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study.
    Leonhardt CS; Kinny-Köster B; Hank T; Habib JR; Shoucair S; Klaiber U; Cameron JL; Hackert T; Wolfgang CL; Büchler MW; He J; Strobel O
    Ann Surg Oncol; 2023 Apr; 30(4):2433-2443. PubMed ID: 36479659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.
    Mendis S; Lipton L; To YH; Ananda S; Michael M; McLachlan SA; Thomson B; Loveday B; Knowles B; Fox A; Nikfarjam M; Usatoff V; Shapiro J; Clarke K; Pattison S; Chee CE; Zielinski R; Wong R; Gibbs P; Lee B
    Br J Cancer; 2024 May; 130(9):1477-1484. PubMed ID: 38448752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.